Cardiothoracic & vascular anesthesia

Use of high‐flow nasal cannula versus other noninvasive ventilation techniques or conventional oxygen therapy for respiratory support following pediatric cardiac surgery: A systematic review and meta‐analysis

Paediatr AnaesthPublished Systematic review and meta-analysis of randomised trials and observational studies

Authors' conclusion

High-flow nasal cannula is more effective in reducing the rate of postextubation failure compared to other forms of noninvasive ventilation techniques following surgery for congenital heart disease in pediatric-aged patients. high-flow nasal cannula is also associated with lower mortality rates and shorter length of stay. However, when comparing high-flow nasal cannula to conventional oxygen therapy, the findings were inconclusive primarily due to a limited number of scientific studies available on this specific comparison.

Study context

Population
Children undergoing cardiac surgery for congenital heart disease, after tracheal extubation
Participants
1,565 children · 12 studies
Comparison
HFNC vs NIV or conventional oxygen therapy after extubation
Outcome
Tracheal reintubation (postextubation failure)

Pooled result

As reported in the abstract

Tracheal reintubation
Relative risk (95% CI)P value
HFNC vs Conventional oxygen therapy
0.67(0.24–1.90)
P = 0.46
HFNC vs NIV
0.45(0.32–0.63)
P < 0.01

Further pooled results

OutcomeRR (95% CI)P value
MortalityHFNC vs NIV0.31 (0.16–0.61)P < 0.01
OutcomeMean difference (days) (95% CI)P value
Postoperative LOSHFNC vs NIV−8.76 (−13.08 to −4.45)P < 0.01
ICU LOSHFNC vs NIV−4.63 (−9.16 to −0.11)P = 0.04

Original publication

Use of high‐flow nasal cannula versus other noninvasive ventilation techniques or conventional oxygen therapy for respiratory support following pediatric cardiac surgery: A systematic review and meta‐analysis. Paediatr Anaesth. Published 22 February 2024. doi:10.1111/pan.14866

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.